Literature DB >> 25527465

Radiological imaging features and clinicopathological correlation of hemosiderotic fibrolipomatous tumor: experience in a single tertiary cancer center.

Dearbhail O'Driscoll1, Edward Athanasian, Meera Hameed, Sinchun Hwang.   

Abstract

OBJECTIVE: To determine the imaging features of hemosiderotic fibrolipomatous tumor (HFLT), which has a propensity towards local recurrence and the potential to transform into myxoinflammatory fibroblastic sarcoma (MIFS).
MATERIALS AND METHODS: The study included 8 patients with a diagnosis of HFLT and imaging at a tertiary cancer center. Imaging studies included radiographs (n = 2), ultrasound (n =  3), and MRI (n = 16). Imaging features were evaluated including location, calcification, sonographic echogenicity, vascular flow, size, border, signal characteristics, contrast enhancement, and blooming on MRI.
RESULTS: The HFLT was located in the ankle/foot in 4 out of 8 and was subcutaneous in 8 out of 8, ranging in size from 2 to 18 cm. Histology at initial diagnosis was HFLT in 5 out of 8 and HFLT with MIFS in 3 out of 8. None was calcified on radiography. On ultrasound 2 out of 3 were heterogeneously echogenic with ≥10 foci of vascular flow. Two out of 8 patients had MRI only at local recurrence. The tumor border was infiltrative in 4 out of 6 at initial diagnosis and in 2 patients with MRI at recurrence only. Fat and septae were present in 7 out of 8 at initial diagnosis and at recurrence. Signal intensity was iso-/hypointense to muscle on T1-weighted sequences in more than two thirds of the tumor in 4 out of 7 and hyperintense to muscle in at least one third of the tumor on fluid-sensitive sequences in 6 out of 8. Contrast enhancement was heterogeneous in 7 out of 7; blooming in two thirds of the tumor on gradient-echo sequence MRI indicated hemorrhage.
CONCLUSION: The HFLT commonly presents as a mass with an infiltrative border, interspersed fat and septations at initial diagnosis and local recurrence on MRI regardless of histology of HFLT alone or with MIFS. Hemosiderin deposits may be detected as blooming on gradient-echo sequences.

Entities:  

Mesh:

Year:  2014        PMID: 25527465     DOI: 10.1007/s00256-014-2078-0

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  19 in total

1.  Hemosiderotic fibrolipomatous tumor, not an entirely benign entity.

Authors:  David A Solomon; Cristina R Antonescu; Thomas M Link; Richard J O'Donnell; Andrew L Folpe; Andrew E Horvai
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

2.  Hemosiderotic fibrohistiocytic lipomatous lesion: ten cases of a previously undescribed fatty lesion of the foot/ankle.

Authors:  C Marshall-Taylor; J C Fanburg-Smith
Journal:  Mod Pathol       Date:  2000-11       Impact factor: 7.842

3.  Inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells: a distinctive lesion with features simulating inflammatory conditions, Hodgkin's disease, and various sarcomas.

Authors:  E A Montgomery; K O Devaney; T J Giordano; S W Weiss
Journal:  Mod Pathol       Date:  1998-04       Impact factor: 7.842

4.  Hemosiderotic fibrohistiocytic lipomatous lesion: early pleomorphic hyalinizing angiectatic tumor?

Authors:  Bostjan Luzar; Gorana Gasljević; Vesna Juricić; Matej Bracko
Journal:  Pathol Int       Date:  2006-05       Impact factor: 2.534

5.  Hemosiderotic fibrohistiocytic lipomatous lesion: clinical correlation with venous stasis.

Authors:  Dmitry V Kazakov; Radek Sima; Michal Michal
Journal:  Virchows Arch       Date:  2005-06-10       Impact factor: 4.064

6.  [Hemosiderotic fibrohistiocytic lipomatous lesion: a new entity you must remind].

Authors:  A Prud'homme; C Rousselot; G de Pinieux; P Voche; P Rosset
Journal:  Ann Chir Plast Esthet       Date:  2007-02-21       Impact factor: 0.660

7.  Pleomorphic hyalinizing angiectatic tumor: analysis of 41 cases supporting evolution from a distinctive precursor lesion.

Authors:  Andrew L Folpe; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-11       Impact factor: 6.394

8.  Acral myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the hands and feet.

Authors:  J M Meis-Kindblom; L G Kindblom
Journal:  Am J Surg Pathol       Date:  1998-08       Impact factor: 6.394

9.  Haemosiderotic fibrolipomatous tumour (so-called haemosiderotic fibrohistiocytic lipomatous tumour): analysis of 13 new cases in support of a distinct entity.

Authors:  T-J Browne; C D M Fletcher
Journal:  Histopathology       Date:  2006-03       Impact factor: 5.087

10.  Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions.

Authors:  Karolin H Hallor; Raf Sciot; Johan Staaf; Markus Heidenblad; Anders Rydholm; Henrik Cf Bauer; Kristina Aström; Henryk A Domanski; Jeanne M Meis; Lars-Gunnar Kindblom; Ioannis Panagopoulos; Nils Mandahl; Fredrik Mertens
Journal:  J Pathol       Date:  2009-04       Impact factor: 7.996

View more
  2 in total

1.  Plexiform fibrohistiocytic tumor: imaging features and clinical findings.

Authors:  Marcus Ghuman; Sinchun Hwang; Cristina R Antonescu; David M Panicek
Journal:  Skeletal Radiol       Date:  2018-08-25       Impact factor: 2.199

2.  Sarcomatous transformation of a hemosiderotic fibrohistiocytic lipomatous tumor: a case report.

Authors:  Renata Margarida Etchebehere; Elia Cláudia Souza Almeida; Carlos David Teixeira Santos; Adilha Misson Rua Micheletti; Antônio Sebastião Leitão
Journal:  Rev Bras Ortop       Date:  2016-11-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.